nach oben

International Journal of Clinical Pharmacy

Erschienen in:

01.04.2007 | Commentary

Provision of pharmaceuticals in Australian hospitals: equity of access?

verfasst von: Gisselle Gallego, Susan J. Taylor, Jo-anne E. Brien

Erschienen in: International Journal of Clinical Pharmacy | Ausgabe 2/2007

Einloggen, um Zugang zu erhalten

Abstract

In Australia, medicines are funded under a complex set of financial arrangements. Currently there are dual funding arrangements in public and private hospitals that can lead to differences in patient access to medications. There are considerable concerns about the consequences of the fragmentation and “lack of cohesion of the system”. Some decision-makers consider there are inequities because of the funding models in place. What follows is a description of this system.

Salked G, Mitchell A, Hill S. Pharmaceuticals. In: Mooney G, Scotton R, editors. Economics and Australian health policy. St Leonards: Allen & Unwin; 1999. ISBN 1 86448 749 6

Commonwealth Department of Health and Ageing. National medicines policy. 2000; http://www.health.gov.au/internet/wcms/publishing.nsf/Content/nmp-objectives-policy.htm/$FILE/nmp2000.pdf (7 September 2006)

Department of Health and Ageing. TGA – therapeutics goods administration. 2006; http://www.tga.gov.au/docs/html/pmeds_reg.htm (7 September 2006)

Duckett SJ. Australian hospital services: An overview. Aust Health Rev 2002; 25(1):2–18

Department of Health Government of Western Australia. Pharmaceutical benefit scheme (PBS) reform. 2006; http://www.health.wa.gov.au/pbsreform/ (7 September 2006)

Department of Health and Ageing. Annual report 2003–2004. Australian health care agreements. http://www.health.gov.au/internet/wcms/publishing.nsf/Content/14C0682D7DFA0F66CA25718E001BCBCC/$File/ar2003-04_full.pdf (7 September 2006)

Sansom L. The subsidy of pharmaceuticals in Australia: processes and challenges. Aust Health Rev 2004; 28(2):194–205PubMedCrossRef

Commonwealth Department of Health and Aged Care. Guidelines for the pharmaceutical industry preparation of submissions to the Pharmaceutical Benefits advisory committee. Canberra: Commonwealth Department of Health and Ageing; 2002. ISBN 0 642 82144 5

Commonwealth Department of Health and Ageing. Schedule of Pharmaceutical Benefits – Section 100 arrangements. 2006; http://www.health.gov.au/internet/wcms/publishing.nsf/content/pbs-schedule-sec100 (7 September 2006)

10.

Victorian Government Health Information. Commonwealth/State highly specialised drugs program guidelines. 2006; http://www.health.vic.gov.au/hsdp/program.htm#Anchor-Program-5249 (7 September 2006)

11.

Donato R, Scotton R. The Australian health care system. In: Mooney G, Scotton R. editors. Economics and Australian health policy. St Leonards, NSW: Allen & Unwin; 1999. ISBN 1 86448 749 6

12.

Department of Health and Ageing. Australian health care agreements. http://www.health.gov.au/internet/wcms/publishing.nsf/Content/Australian+Health+Care+Agreements-1 (7 September 2006)

13.

Department of Health and Ageing. The state of our public hospitals, June 2004 report. http://www.health.gov.au/internet/WCMS/publishing.nsf/Content/health-ahca-sooph-index.htm/$FILE/sooph2004.pdf (7 September 2006)

14.

Australian Institute of Health and Welfare (AIHW). Australia’s health 2004. Canberra: AIHW; 2004. ISBN 1 74024 382 X

15.

Australian Bureau of Statistics. Year book Australia. Health care delivery and financing. 2006; http://www.abs.gov.au/Ausstats/abs@.nsf/94713ad445ff1425ca25682000192af2/98de259e1e8f1cb3ca256f7200832f37!OpenDocument (7 September 2006)

16.

McAuley I. Stress on public hospitals – why private insurance has made it worse. Canberra: Australian Consumers Association and the Australian Healthcare Association; 2004

17.

Blendon RJ, Schoen C, DesRoches CM, Osborn R, Zapert K, Raleigh E. Confronting competing demands to improve quality: a five-country hospital survey. Health Aff 2004; 23(3):119–135CrossRef

18.

Royal Australasian College of Physicians. Response to the senate inquiry into public hospital funding. Sydney: Royal Australasian College of Physicians; 1999

19.

Duckett SJ, Jackson TJ. The new health insurance rebate: an inefficient way of assisting public hospitals. Med J Aust 2000; 172(9):439–442PubMed

20.

The Society of Hospital Pharmacists of Australia (SHPA). Moving forward – the funding of medicines in Australia’s hospitals. Melbourne: The Society of Hospital Pharmacists of Australia (SHPA); 2004

21.

National Health Strategy. Issues in pharmaceutical drug use in Australia. Issue paper no.4. Canberra: Department of Health, Housing and Community Services; 1992. ISBN

22.

Commonwealth Department of Health and Aged Care. The Australian health care system, an outline. Canberra: ACT, Publications Unit, Commonwealth Department of Health and Aged Care; 2000. ISBN 0 642 44730 6

23.

Victorian Therapeutic Advisory Group VicTAG. Hospital price and resource allocation review: good practice model for controlling medicines costs in hospitals. Melbourne: Victorian Therapeutics Advisory Group; 2004

24.

Australian Institute of Health and Welfare (AIHW). Australian hospital statistics 2002–2003. Canberra: AIHW; 2004. ISBN 1036-613X

25.

Commonwealth Department of Health and Ageing. Schedule of pharmaceutical benefits for approved pharmacists and medical practitioners – chemotherapy pharmaceuticals access program supplement. http://www.health.gov.au/internet/wcms/publishing.nsf/Content/986ABF111B7A5183CA256F180048C850/$File/pbschemo_aug06.pdf (7 September 2006)

26.

O’Leary KM, Allison YM. Pharmacy distribution service delivery models in use in Australian public. J Pharm Pract Res 2004; 34(2):114–121

27.

Larmour I, Thomson WA, TSui MK, Weeks GR. Introduction of Pharmaceutical Benefits scheme reforms at three Victorian public health services. J Pharm Pract Res 2003; 33:204–207

28.

Senate Community Affairs Reference Committee. Public founding and options for reform. First report. Canberra: Senate Community Affairs Reference Committee; 2000. ISBN 0 642 71044 9

29.

Low J. Negotiating access to PBS medicines in public hospitals. Aust J Pharm 2003; 84(December):928

30.

Department of Health Government of Western Australia. Western Australia drugs and therapeutics committee (WATAG). http://www.watag.org.au/home/ (7 September 2006)

31.

Queensland Government (Queensland Health). Queensland health policy/guidelines. Availability of pharmaceuticals. http://www.health.qld.gov.au/phs/Documents/pas/566.pdf (7 September 2006)

32.

Hall J. Incremental change in the Australian health care system. Health Aff 1999; 18(3):95–110CrossRef

33.

Allinson Y. Funding of pharmaceuticals in public hospitals: PBS under the probe. Healthcover 2001; 11(2):58–63

Titel: Provision of pharmaceuticals in Australian hospitals: equity of access?
verfasst von: Gisselle Gallego
Susan J. Taylor
Jo-anne E. Brien
Publikationsdatum: 01.04.2007
Verlag: Kluwer Academic Publishers
Erschienen in: International Journal of Clinical Pharmacy / Ausgabe 2/2007
Print ISSN: 2210-7703
Elektronische ISSN: 2210-7711
DOI: https://doi.org/10.1007/s11096-006-9066-y

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

25.04.2024 | Hypotonie | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Provision of pharmaceuticals in Australian hospitals: equity of access?

Abstract

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Viel Bewegung in der Parkinsonforschung

Adjuvante Immuntherapie verlängert Leben bei RCC

Update Innere Medizin

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2007

Determinants of potential drug–drug interaction associated dispensing in community pharmacies in the Netherlands

Ascertaining consumer perspectives of medication information sources using a modified repertory grid technique

Self-reported medication and lifestyle adherence in Hungarian patients with Type 2 diabetes

The quality of self-care counselling by pharmacy practitioners, supported by IT-based clinical guidelines

Off-label prescribing in a French hospital

Prioritising drug and therapeutics committee (DTC) decisions: a national survey

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Viel Bewegung in der Parkinsonforschung

Adjuvante Immuntherapie verlängert Leben bei RCC

Update Innere Medizin